PATENT CLAIM ANALYSIS

Application Number: 15951953
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2019-03
Patent Classification: ["424", "472000"]

Abstract:
This application relates to pharmaceutical compositions, comprising solabegron that are useful for the treatment of lower urinary tract symptoms such as, for example, overactive bladder and prostate disorders. Additionally, this application relates to methods for treating lower urinary tract symptoms utilizing the pharmaceutical compositions, comprising solabegron. In some embodiments, the pharmaceutical compositions, comprising solabegron comprise a dual release drug delivery system.

Claim (Index 79):
The method of  claim 55 , wherein the pharmaceutical composition achieves the second target C max  in about 4 hours to about 6 hours after the first C min .

Metadata:
- Claim Count in Document: 168.0
- Percentile: 91.0
- Lexical Diversity: 1.61364
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14958610', '13160572', '13001516', '14367972', '12744301']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7165890691571901
- 35 USC 102 Novelty (BERT): 0.54461373811494
- Combined Prediction Score: 0.6993915360529651
- Mean Citation Score: 248.485146
- Max Citation Score: 398.12674
- Similarity Product: 291.4987276604056

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test